Rtw Investments »

Belite Bio shares owned by Rtw Investments

Quarter-by-quarter ownership of Belite Bio (BLTE) shares owned by Rtw Investments from 13F filings

Historical chart of Rtw Investments investment in Belite Bio

Tip: Access up to 7 years of quarterly data

All positions including Belite Bio held by Rtw Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Belite Bio by Rtw Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $23M 313k 74.00

More positions owned by Rtw Investments

Madrigal Pharmaceuticals (MDGL)
Argenx Se Sponsored Adr (ARGX)
Avidity Biosciences Ord (RNA)
Ptc Therapeutics I (PTCT)
Insmed Com Par $.01 (INSM)
Protagonist Therapeutics (PTGX)
Natera (NTRA)
Akero Therapeutics (AKRO)
Uniqure Nv SHS (QURE)
Penumbra (PEN)
RadNet (RDNT)
Merus N V (MRUS)
Tarsus Pharmaceuticals (TARS)
Stryker Corporation (SYK)
Immunocore Hldgs Ads (IMCR)

View all positions for Rtw Investments

Top funds holding Belite Bio

RA Capital Management
Rtw Investments
Vestal Point Capital
Soleus Capital Management
Eventide Asset Management
Marshall Wace
Perceptive Advisors
Millennium Management
Geode Capital Management
State Street Corporation
Bnp Paribas Arbitrage, Snc
UBS Group
Citadel Advisors
Jpmorgan Chase & Co
Polymer Capital Management

View all funds holding Belite Bio